Tenderwize
Back to tender search

Open House Original Discount Agreements 2025-14 - Tiotropiumbromid/Olodaterol (Combination of Active Substances)

Techniker Krankenkasse·Hamburg, Germany·Deadline May 30, 2027 · 284 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-14 - Tiotropiumbromid/Olodaterol (Wirkstoffkombination)

50/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

30 / 100

Risk factors

The notice clarifies this is not a public procurement subject to procurement law, but an Open House. Legal recourse is...

No estimated value or volume provided; the actual demand under the agreement is unknown. Potential low uptake if other...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of Tiotropiumbromid/Olodaterol combination drug (COPD treatment).
  • Entering into a discount agreement (Rabattvertrag) under §130c SGB V with TK, HEK, and hkk.
Show full summary

Open House (non-competitive) procedure by Techniker Krankenkasse and other insurers to conclude discount agreements for the drug combination Tiotropiumbromid/Olodaterol. Eligible pharmaceutical entrepreneurs can join at any time during the contract period (01.06.2025-31.05.2027). No estimated value provided. All eligible suppliers are accepted; no award criteria.

Risks

The notice clarifies this is not a public procurement subject to procurement law, but an Open House. Legal recourse is...

No estimated value or volume provided; the actual demand under the agreement is unknown. Potential low uptake if other...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Participant must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) under AMG §4(18) for the offered drug.
  • Must have a valid marketing authorization for the drug combination under AMG §21(1) or equivalent right to market.

Certifications

  • Must certify no exclusion grounds under GWB §§123-124 (self-declaration required).

Requirements may be incomplete.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Original Discount Agreements 2025-14 - Tiotropiumbromid/Olodaterol (Combination of Active Substances)

Setting up a discount agreement for the supply of Tiotropiumbromid/Olodaterol combination drug to TK and partner insurers. Open to all eligible pharmaceutical entrepreneurs during the contract period.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Deadline

Deadline May 30, 2027

Procurement Details

Publication date
16 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
251794-2025

Documents (1)

Similar tenders